GlaxoSmithKline Consumer Healthcare (GSK) has reported nearly 3% rise in standalone net profit for the first quarter (Q1) ended on June 30, 2016.
The net profit of GlaxoSmithKline Consumer Healthcare for the April-June quarter of the fiscal year 2016-17 (FY17) grew by 2.92% to Rs 16,061 lakh as against Rs 15,605 lakh in the corresponding quarter of previous fiscal, cited the company in a filing to the Bombay Stock Exchange (BSE) on Friday.
Its total income from operations during Q1 FY17 rose up by 1.36% to Rs 105,938 lakh as compared to Rs 107,395 lakh in Q1 FY16.
The company's total expenses during the period under review fell down by 2.01% to Rs 87,053 lakh as against Rs 88,836 lakh in the same period of last fiscal.
At 14:30 hours, on Friday, the stock of GlaxoSmithKline Consumer Healthcare (GSK) was trading down 3.13% or Rs 198.60 at Rs 6,156.00 on the BSE.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Hit by strike, GSK Consumer temporarily suspends operations at Punjab plant
GSK Consumer Healthcare tanks nearly 5% in early trade post weak Q4 earnings